Company Overview
  R&D Center

The Central Research Institute of Samik
Pharmaceutical Co., Ltd.
 
Research achievement & status
 
Present condition of patent application and registration
- 10-0821208 Composition comprising meloxicam having improved bioavailability
and process for preparation thereof
- 10-2148374 Bilayer coated tablet comprising choline alfoscerate and a method
for producing the same
- 10-2242382 A syrup composition comprising loratadine, having improved
solubility, stability and bitter taste

The current completion condition for bioequivalence Test
- Aceclofenac
- Acetaminophen/Tramadol Hydrochloride
- Amlodipine Besylate (as amlodipine)
- Atorvastatin Calcium (as atorvastatin)
- Clopidogrel Bisulfate (as clopidogrel)
- Dapagliflozin Propanediol Hydrate
- Dapagliflozin Propandiol Hydrate/Sitagliptin Phosphate Hydrate
- Dapagliflozin Propanediol Hydrate/Metformin Hydrochloride
- Famotidine
- Fluconazole
- Glimepiride
- Lafutidine
- Levocetirizine Dihydrochloride
- Levodropropizine
- Losartan Potassium (as losartan)
- Losartan Potassium (as losartan)/Hydrochlorothiazide
- Loxoprofen Sodium Hydrate (as loxoprofen sodium)
- Meloxicam
- Metformin Hydrochloride
- Ofloxacin
- Olmesartan Medoxomil
- Olmesartan Medoxomil/Hydrochlorothiazide
- Pioglitazone Hydrochloride (as pioglitazone)
- Pregabalin
- Rebamipide
- Rosuvastatin Calcium (as rosuvastatin)
- Sitagliptin Phosphate Hydrate
- Sitagliptin Phosphate Hydrate/Pioglitazone Hydrochloride
- Sitagliptin Phosphate Hydrate/Metformin Hydrochloride
- Sodium Alendronate (as alendronic acid)
- Valsartan/Amlodipine Besylate (as amlodipine)